The effect of hemoglobin level on radiotherapy outcomes: The Canadian experience

Seminars in Oncology

Volumn 28, Issue 2 SUPPL. 8, 2001, Pages 60-65

  Thomas, Gillian ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANEMIA; ARTICLE; BLOOD TRANSFUSION; CANADA; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; FEMALE; HEMOGLOBIN DETERMINATION; HUMAN; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME; UTERINE CERVIX CARCINOMA;

EID: 0034994669     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/sonc.2001.25400     Document Type: Article

References (18)

1. Prognostic value of hemoglobin concentrations and blood transfusions in advanced carcinoma of the cervix treated by radiation therapy: Results of a retrospective study of 386 patients
2. Radiotherapy and anaemia - The clinical experience
3. The prognostic value of hemoglobin and a decrease in hemoglobin during radiotherapy in laryngeal carcinoma
4. Prognostic value of hemoglobin concentration in radiotherapy for cancer of supraglottic larynx
5. The impact of blood hemoglobin content on the outcome of radiotherapy. The Freiburg experience
6. Anemia is associated with decreased survival and increased locoregional failure in patients with locally advanced head and neck carcinoma: A secondary analysis of RTOG 85-27
7. Radiation, hypoxia and genetic stimulation: Implications for future therapies
8. Relevance of oxygen in radiation oncology, mechanisms of action, correlation to low hemoglobin levels
9. Oxygenation of human tumors: The Mainz experience
10. Hemoglobin level and anemia in radiation oncology: Prognostic impact and therapeutic implications
11. Transfusion medicine. First of two parts. Blood transfusions
12. The importance of hemoglobin levels during radiotherapy for carcinoma of the cervix
13. Low hemoglobin is associated with increased serum levels of vascular endothelial growth factor (VEGF) in cancer patients. Does anemia stimulate angiogenesis?
14. Erythropoietin increases hemoglobin in cancer patients during radiation therapy
15. Clinical trial experience using erythropoietin during radiation therapy
16. Erythropoietin increases hemoglobin during radiation therapy for cervical cancer
17. Effect of the administration of recombinant human erythropoietin in patients with pelvic malignancies during radiotherapy
18. Once-weekly dosing of epoetin alfa increases hemoglobin and improves quality of life in anemic cancer patients receiving radiation therapy either concomitantly or sequentially with chemotherapy